Sugi Predict

Sugi Predict / Compounds / SCHEMBL10276789

SCHEMBL10276789

SCHEMBL10276789

[Cl].[Rh].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.86
▸ CYP3A4 P08684 1/20 0.86
▸ ESR1 P03372 4/20 0.60
▸ ESR2 Q92731 4/20 0.60
▸ KDM4E B2RXH2 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ DRD1 P21728 2/20 0.34
▸ TSHR P16473 4/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ CA12 O43570 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ CA3 P07451 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ CA14 Q9ULX7 1/20 0.32
▸ ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788643 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL9169400 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL375622 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL10565176 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL1982595 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL1013946 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL852493 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL19097318 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL6320882 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Bromide SCHEMBL9510236 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112029464-A Cross dehydrogenation coupling reaction-based low-modulus MS sealant and preparation method thereof 郑州大学 2020-12-04 — — CN claimed
EP-4543869-B1 N-(2-(3-CYANO-2-AZABICYCLO[3.1.0]HEXAN-2-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES ASTRAZENECA AB (SE) 2026-05-27 — — EP disclosed
EP-4729516-A1 SUBSTITUTED IMIDAZOLE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu NHWA Pharmaceutical Co., Ltd (CN) 2026-04-22 — — EP disclosed
EP-3898706-B1 PROCESS FOR PREPARING HNBR SOLUTIONS WITH ALTERNATIVE SOLVENTS ARLANXEO DEUTSCHLAND GMBH (DE) 2025-10-01 — — EP disclosed
CN-120136929-A Ruthenium-based catalyst, preparation method thereof and application of ruthenium-based catalyst in preparation of hydrogenated nitrile rubber in organic solvent 山东链科新材料有限公司 2025-06-13 — — CN disclosed
WO-2024260319-A1 SUBSTITUTED IMIDAZOLE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD THEREFOR AND USE THEREOF 江苏恩华药业股份有限公司 2024-12-26 — — WO disclosed
EP-3898707-B1 PROCESS FOR PRODUCING PEG ACRYLATE-HNBR COPOLYMER ARLANXEO DEUTSCHLAND GMBH (DE) 2024-09-18 — — EP disclosed
US-11998539-B2 Substituted aminoquinolones as DGKalpha inhibitors for immune activation BAYER AKTIENGESELLSCHAFT (DE) 2024-06-04 — — US disclosed
US-11958924-B2 Process for preparing HNBR solutions with alternative solvents ARLANXEO DEUTSCHLAND GMBH (DE) 2024-04-16 — — US disclosed
CN-117801284-A Preparation process of low-odor colorless polyether modified silicone oil 万华化学集团股份有限公司 2024-04-02 — — CN disclosed
US-20160221890-A1 SILP CATALYST FOR HYDROFORMYLATION OF OLEFINS WITH SYNTHESIS GAS EVONIK DEGUSSA GMBH (DE) 2016-08-04 — — US disclosed
US-9140657-B2 Detection of J-coupling using atomic magnetometer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-09-22 — — US disclosed
US-8962894-B2 Process for preparing 1, 6-hexanediol E I DU PONT DE NEMOURS AND COMPANY (US) 2015-02-24 — — US disclosed
EP-2797867-A1 PROCESS FOR PREPARING 1, 6-HEXANEDIOL E. I. Du Pont de Nemours and Company (US) 2014-11-05 — — EP disclosed
US-8865940-B2 Process for preparing 1,6-hexanediol E I DU PONT DE NEMOURS AND COMPANY (US) 2014-10-21 — — US disclosed
CN-104011002-A Process for preparing 1, 6-hexanediol DU PONT 2014-08-27 — — CN disclosed
US-20140228596-A1 PROCESS FOR PREPARING 1,6-HEXANEDIOL E I DU PONT DE NEMOURS AND COMPANY (US) 2014-08-14 — — US disclosed
US-20130172578-A1 PROCESS FOR PREPARING 1, 6-HEXANEDIOL E I DU PONT DE NEMOURS AND COMPANY (US) 2013-07-04 — — US disclosed
WO-2013101969-A1 PROCESS FOR PREPARING 1, 6-HEXANEDIOL E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-07-04 — — WO disclosed
US-20120176130-A1 Detection of J-Coupling Using Atomic Magnetometer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221890-A1 SILP CATALYST FOR HYDROFORMYLATION OF OLEFINS WITH SYNTHESIS GAS SLIRP, CCNH, SSRP1 TDP1 4353/4885CYP3A4 1699/4885ESR1 1102/4885
US-20130172578-A1 PROCESS FOR PREPARING 1, 6-HEXANEDIOL PGD, G6PD, HK1 TDP1 2534/4885CYP3A4 431/4885ESR1 3075/4885
US-11998539-B2 Substituted aminoquinolones as DGKalpha inhibitors for immune activation DGKK, DGKG, DGKA TDP1 1336/4885CYP3A4 3174/4885ESR1 2975/4885
US-20140228596-A1 PROCESS FOR PREPARING 1,6-HEXANEDIOL PGD, G6PD, HK1 TDP1 1625/4885CYP3A4 976/4885ESR1 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.